Precision Medicine Speakers:

Julien De Salaberry  , Managing Director,  The Asia HealthTech Connector
David Smith 
, Professor,  Mayo Clinic        
Jay Goth 
, Managing Member,  Forentis Fund
Marie-Claire Parker 
, Business Development Manager,  Scottish Stratified Innovation Medical Center
Marilyn Robertson 
, Ecosystem Manager,  Scottish Stratified Innovation Medical Center
Tony Freemont 
, Professor of Osteoarticular Pathology,  Manchester University
Melina Kalofonou 
, Postdoctoral Researcher,  Imperial College London
Julia Wilson 
, Associate Director,  Wellcome Trust Sanger Institute
Janette Rawlinson 
, Lay Member,  CRUK Stratified Medicine Programme
Christophe Le Tourneau 
, Head of Phase I programme & Co-head of the Clinical Trial Unit,  Institut Curie
Ansar Jawaid 
, Founder and Chief Executive Officer,  Precision Medicines
Pantelis Grorgiou 
, Senior Lecturer,  Imperial College London
Jacqui Shaw 
, Professor of Translational Cancer,  University of Leicester
Seshandri Vasan 
, Senior Business Development Manager,  University of York, Public Health England         
Maria Chatzou 
, Research Bioinformatics Engineer & President,  Innovation Forum Barcelona Centre for Genomic Regulation
Joanne Mason 
, Director of Sequencing and Sample Acquisition,  Genomics England           
Clare Turnbull 
, Senior Researcher in Cancer Genomics,  Institute of Cancer Research
Jean-Louis Mandel 
, Professor of Human Genetics, College de France,  University of Strasbourg
Gil Alterovitz 
, Assistant Professor,  Harvard/MIT 
Chase Miller 
, Director of Research and Science, Eccles Department of Genetics,  University of Utah
Nikole Kimes 
, Co-Founder and Vice President,  Siolta Therapeutics
Jean Louis Mandel 
, Professor of Human Genetics,  Collège de France
Paul-Peter Tak 
, Senior Vice President of Research and Development Pipeline, Chief Immunology Officer,  GSK
Dipak Kalra 
, President,  EuroRec
Alain Thierry 
, Research Director,  INSERM
Sudhakaran Prabakaran 
, Lecturer, Department of Genetics,  Cambridge University
Juergin Eils 
, Group Leader,  German Cancer Research Centre
Anthony Whetton 
, Director, Stoller Biomarker Discovery Centre,  University of Manchester
Sue Hill 
, Chief Scientific Officer,  NHS
 

AGENDA OVERVIEW:

 
 

DAY 1

OPENING KEYNOTES

PLATINUM SPONSOR ADDRESS

MORNING BREAK

PLENARY ROUNDTABLE SESSION

SPEED NETWORKING

LUNCH

Big data and genomics

  • Data sharing
  • Standardisation
  • Empowering data for clinical use
  • Analytics and applications
  • Clinical infrastructure
  • Privacy, security and ethics

 

Genomic medicine

  • New initiatives for precision medicine
  • Promoting clinical engagement
  • Building public confidence in sharing data and tissue
  • Infrastructure and investment

Drug discovery and development

  • Target discovery & data for drug development
  • Therapeutic rediscovery and new translational hurdles
  • Clinical trial design & pharmacology
AFTERNOON REFRESHMENTS PLENARY KEYNOTE

POSTER ZONE & NETWORKING DRINKS  

 

DAY 2

OPENING KEYNOTES

PLATINUM SPONSOR ADDRESS

MORNING BREAK

Enabling genomic data using machine learning and AI

  • Applications for AI and machine learning in clinical development
  • Predictive modelling 
  • Applications in oncology
  • Integrating patient and genomic data

Wearables and digital health

  • The digi-health revolution and how to support it
  • Integrating personal and wearable devices into the clinic

Drug development and companion diagnostic

  • Partnership, regulation & clinical access
  • Drivers, checkpoints & other obstacles
  • NGS platforms and ctDNA

 

Healthcare track

  • How is precision medicine affecting clinical practice?
  • New translational solutions for genomic medicine
LUNCH

Data storage and management

  • Security and protection
  • Electronic health records and security
  • Improving hardware and information architecture
  • Using the cloud

Next generation sequencing

  • NGS platforms and ctDNA

Medical devices for genomics

  • New technologies for collecting data
  • Dealing with the data from digi health

Healthcare track

  • Genetic counselling
  • Practical clinical techniques for precision medicine
AFTERNOON REFRESHMENTS PLENARY KEYNOTE

POSTER ZONE & NETWORKING DRINKS  

 

 

DAY 3

Rare disease and orphan drugs

  • Supporting systems and infrastructure for rare diseases
  • Regulations and guidelines
  • Applying precision medicine to rare diseases
  • Clinical development
  • Patient access

Cancer genomics

  • Tumour heterogeneity, ctDNA and liquid biopsy
  • Translation of cancer research into the clinic
  • Predicting cancer dependencies from cancer genomics
  • New analytical technologies

LUNCH

CLOSING PLENARY: What to watch out for in 2018?

 

DOWNLOAD PROSPECTUS

To exhibit or sponsor call  Erica Baeta  on
+44(0) 207 092 1152  or email  erica.baeta@terrapinn.com         

 

 

The World Advanced Therapies & Regenerative Medicine Congress is two events: a world-class conference where hundreds of pharma, biotech and academia leaders from around the planet meet and a fantastic exhibition. To visit the show is free. There is, naturally, a registration fee to attend the conference. 

CONTACT US 
phone: +44 (0)207 092 1237 
email: 
  
jessica.robinson@terrapinn.com